MedPath

Brim-Dor PF

Approved
Approval ID

6bb58e03-7db3-23a2-e053-2a91aa0a8800

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 8, 2018

Manufacturers
FDA

ImprimisRx NJ

DUNS: 931390178

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brimonidine - Dorzolamide PF

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70261-518
Product Classification
G
Generic Name
Brimonidine - Dorzolamide PF
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMay 8, 2018
FDA Product Classification

INGREDIENTS (2)

BRIMONIDINE TARTRATEActive
Quantity: 1.5 mg in 1 mL
Code: 4S9CL2DY2H
Classification: ACTIM
DORZOLAMIDE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: QZO5366EW7
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Brim-Dor PF - FDA Drug Approval Details